Cargando…
New Insights in the Management of Antipsychotics in the Treatment of Schizophrenia in a Patient with Prolactinoma: A Case Report and Review of the Literature
Prolactinomas are the commonest pituitary adenomas and the major pathological cause of hyperprolactinaemia. Symptomatic prolactinomas are treated mainly by dopamine agonists; surgery and radiotherapy are options for nonresponders. Schizophrenia treatment is based on antipsychotics, which acts mainly...
Autores principales: | Santos Andrade, Elvis Henrique, Pan, Pedro Mario, da Silva, Paula F. Ramalho, Gadelha, Ary |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2977938/ https://www.ncbi.nlm.nih.gov/pubmed/21076684 http://dx.doi.org/10.1155/2010/573252 |
Ejemplares similares
-
Successful treatment of a prolactinoma with the antipsychotic drug aripiprazole
por: Bakker, Ilse C A, et al.
Publicado: (2016) -
SAT620 Dopamine Challenge: Treatment Of Pituitary Macroadenoma/Prolactinoma In Patient On Antipsychotic Medication
por: Bazhenov, Aleksei, et al.
Publicado: (2023) -
Managing Prolactinomas during Pregnancy
por: Almalki, Mussa Hussain, et al.
Publicado: (2015) -
Current Challenges in the Management of Prolactinomas
por: Maiter, Dominique
Publicado: (2015) -
Italian Guidelines for the Management of Prolactinomas
por: Cozzi, Renato, et al.
Publicado: (2023)